NDC 68180-588

Ramipril 1.25 mg capsule

On the label: Lupin Pharmaceuticals, Inc..

Where it's made

Recalls

• Oct 23, 2024 · Class II · Lupin Pharmaceuticals Inc.
  CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
  Lots: a) NDC 68180-589-09; Lots G326781, exp. date 30-Sep-25, GA04468, exp. date 31-May-25 b) NDC 68180-589-01; Lots G326763, exp. date 30-Sep-25, GA03041, exp. date 31-Mar-26, GA03725, exp. date 30-Apr-26, GA04402, exp. date 31-May-26, c) NDC 68180-589-02; Lots G326782, exp. date 30-Sep-25, …
• Oct 23, 2024 · Class II · Lupin Pharmaceuticals Inc.
  CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
  Lots: a) NDC 68180-590-09; Lots G326928, exp. date 30-Sep-25, GA00964, exp. date 31-Dec-25, b) NDC 68180-590-01, Lots G326897, G326929, exp. date 30-Sep-25, GA00854, GA00933, GA00954, exp. date 31-Dec-25, c) NDC 68180-590-02, Lot GA00955, exp. date 31-Dec-25
• Oct 23, 2024 · Class II · Lupin Pharmaceuticals Inc.
  CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
  Lots: a) NDC 68180-591-09; Lots G327086, exp. date 30-Sep-25 GA01065, exp. date 31-Dec-25, b) NDC 68180-591-01 Lots G325033, G324987, exp. date 31-Jul-25, G325110, GA00956, GA01066, GA01126, exp. date 31-Dec-25, GA03299, GA03288, GA03287, exp. date 31-Mar-26 c) NDC 68180-591-02 Lot GA05919, exp. d…

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Ramiprilat: every company that makes it

Form

capsule, oral

Strength

1.25 mg

Approval

ANDA ANDA077626

On the market since

Jun 10, 2008

Package NDCs

68180-588-01 68180-588-02 68180-588-09

Official label

DailyMed (National Library of Medicine), updated Aug 24, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?